FDA held a public hearing on psychedelic therapies as Trump's push to speed approvals gathered pace

What happened: The FDA held a four-hour public hearing in Silver Spring, Maryland on psychedelic therapies, with doctors, veterans and pharmacists testifying on safety standards, access and provider training. Key numbers: Four-hour session. Why it matters: The hearing took place as Trump's push to speed approvals gathered pace, signaling regulatory attention to how psychedelic therapies could be reviewed and accessed.

The FDA held a four-hour public hearing in Silver Spring, Maryland on psychedelic therapies, with doctors, veterans and pharmacists testifying on safety standards, access and provider training.

The hearing took place as Trump's push to speed approvals gathered pace, signaling regulatory attention to how psychedelic therapies could be reviewed and accessed.